Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The results status changed from 'No Results Posted' to 'Results Submitted', indicating that outcome data are being submitted for posting and will be available after processing.
    Difference
    0.1%
    Check dated 2026-05-29T13:35:27.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A PubMed citation related to the study was added to the Publications section. A line noting that some publications are automatically filled from PubMed was included.
    Difference
    0.2%
    Check dated 2026-05-22T11:13:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new page revision tag, Revision: v3.5.4, was added, replacing the prior Revision: v3.5.3 to reflect an update to the page's version.
    Difference
    0.1%
    Check dated 2026-05-15T07:40:36.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator is updated from v3.5.2 to v3.5.3, reflecting a minor site release without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:52.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:07:51.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.